{"schema_version":"secwatch.filing_event.v1","accession":"0001933414-23-000009","form_type":"8-K","ticker":"MLYS","cik":"0001933414","company_name":"Mineralys Therapeutics, Inc.","filed_at":"2023-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.465504+00:00","generated_at":"2026-06-18T02:32:33.998375+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mineralys FY2022 net loss $29.8M; cash $110.1M plus $202M IPO; lorundrostat pivotal trials H1 2023","bullets":["Net loss for FY2022 was $29.8M vs $19.4M in FY2021, driven by higher R&D and G&A costs.","Cash and marketable securities were $110.1M at Dec 31, 2022; Feb 2023 IPO raised net ~$202M.","Positive Phase 2 Target-HTN data presented; FDA end-of-Phase 2 meeting completed.","Pivotal ADVANCE-HTN Phase 2 trial planned H1 2023; Phase 3 trial planned H2 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001933414-23-000009","json":"https://secwatch.observer/filing/0001933414-23-000009.json","markdown":"https://secwatch.observer/filing/0001933414-23-000009.md","text":"https://secwatch.observer/filing/0001933414-23-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1933414/000193341423000009/0001933414-23-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1933414/000193341423000009/mlys20230315-8kfy2022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T02:32:33.998375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ead8b4aa4165a345d73804284a512730f5ec6a59","claim":"Mineralys Therapeutics, Inc. reported the full-year ended December 31, 2022 results: net income $29.8 million.","evidence_excerpt":"Net loss was $29.8 million for the full year ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341423000009/0001933414-23-000009-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full-year ended December 31, 2022"},{"label":"Net income","value":"$29.8 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}